1Cause of death. United States Renal Data System. Am J Kidney Dis, 1998, 32; S81-88.
2Devereux RB,de Simone G, Koren MJ, et al. Left ventricular mass as a predictor of development of hypertension. Am J Hypertens, 1991, 4: 603S-607S.
3Ganau A, Devereux RB, Roman M J, et M. Patterns of left ventricular hypertrophy and geometric remodeling in essential hypertension. 3 Am Coll Cardiol, 1992, 19 : 1559-1560.
4Cockcroft DW,Gault MH. Predicton of creatinine clearance from serum creatinine. Nephron, 1976, 16: 31-41.
5Nardi E,Paletrmo A, Mule G, et al. Left ventricular hypertrophy and geometry in hypertensive patients with chronic kidney disease. J Hypertens, 2009, 27: 633-641.
6Mark PB, Patel RK, Jardine AG. Are we overestimating left ventricular abnormalities in end-stage renal disease? Nephrol Dial Transplant, 2007, 22 : 1815-1819.
7Paoletti E, Bellino D, Cassottana P, et al. Left Ventricular Hypertrophy in Nondiabetic Predialysis CKD. Am J Kidney Dis, 2005, 46: 320-327.
8McMullen JR,Sherwood MC, Tamavski O, et al. Inhibition of roTOR signaling with rapamyein regresses established cardiac hypertrophy induced by pressure overload. Circulation, 2004, 109 : 3050-3055.
9Strozecki P, Adamowicz A, Nartowicz E, et al. Parathormon, calcium, phosphorus, and left ventricular structure and function in normotensive hemodialysis patients. Ren Fail, 2001, 23 : 115- 126.
10Ritz E. Left ventricular hypertrophy in renal disease: beyond preload and afterload. Kidney Int, 2009, 75 : 771-773.
